{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:31:27Z","timestamp":1787790687210,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000130","name":"National Center for Chronic Disease Prevention and Health Promotion","doi-asserted-by":"publisher","award":["200-2016-91773"],"award-info":[{"award-number":["200-2016-91773"]}],"id":[{"id":"10.13039\/100000130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI129709-03S1"],"award-info":[{"award-number":["AI129709-03S1"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-024-01346-2","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T03:01:54Z","timestamp":1728702114000},"page":"1887-1896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-6920","authenticated-orcid":false,"given":"Yasin","family":"Abul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Vishnepolskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandi","family":"Winkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi Tanvee","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa R.","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Recker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kaczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Kamojjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pralea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailee","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubunmi","family":"Osias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladayo A.","family":"Oyebanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olajide","family":"Olagunju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Jung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walther M.","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"McNicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Mujahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakeena","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Canaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro B.","family":"Balazs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"issue":"3","key":"1346_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1473-3099(23)00684-9","volume":"24","author":"Y Xie","year":"2023","unstructured":"Xie Y, Choi T, Al-Aly Z. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. Lancet Infect Dis. 2023;24(3):239\u201355. https:\/\/doi.org\/10.1016\/S1473-3099(23)00684-9.","journal-title":"Lancet Infect Dis"},{"key":"1346_CR2","unstructured":"Centers for Medicare&Medicaid Services. COVID-19 nursing home data. Available at: https:\/\/data.cms.gov\/covid-19\/covid-19-nursing-home-data. Accessed 1 Jul 2024."},{"key":"1346_CR3","unstructured":"CDC: risk assessment summary for SARS CoV-2 Sublineage BA.2.86. Available at https:\/\/www.cdc.gov\/respiratory-viruses\/whats-new\/covid-19-variant.html. Accessed 2 Feb 2024."},{"key":"1346_CR4","unstructured":"Update on SARS-CoV-2 variant JN.1 being tracked by CDC. Available at https:\/\/www.cdc.gov\/respiratory-viruses\/whats-new\/SARS-CoV-2-variant-JN.1.html. Accessed 26 Jun 2024."},{"key":"1346_CR5","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku Y, Okumura K, Padilla-Blanco M, et al. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect Dis. 2024;24:e82.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1346_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas D, Staropoli I, Michel V, Lemoine F, et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat Commun. 2024;15(1):2254. https:\/\/doi.org\/10.1038\/s41467-024-46490-7.","journal-title":"Nat Commun"},{"key":"1346_CR7","unstructured":"COVID Data Tracker Variant Proportions. Available at https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions."},{"key":"1346_CR8","doi-asserted-by":"publisher","first-page":"104066","DOI":"10.1016\/j.ebiom.2022.104066","volume":"80","author":"DH Canaday","year":"2022","unstructured":"Canaday DH, Oyebanji OA, White E, et al. COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents. EbioMed. 2022;80:104066.","journal-title":"EbioMed"},{"key":"1346_CR9","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1016\/j.vaccine.2023.04.034","volume":"41","author":"C Nugent","year":"2023","unstructured":"Nugent C, Abul Y, White EM, et al. Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Vaccine. 2023;41:3403\u20139.","journal-title":"Vaccine"},{"key":"1346_CR10","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1111\/jgs.18557","volume":"71","author":"OA Oyebanji","year":"2023","unstructured":"Oyebanji OA, Abul Y, Wilson BM, et al. Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residents. J Am Geriatr Soc. 2023;71:3947\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"1346_CR11","unstructured":"CDC COVID Data Tracker: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home. Accessed 3 Jan 2023"},{"key":"1346_CR12","first-page":"e239","volume":"4","author":"S Gravenstein","year":"2023","unstructured":"Gravenstein S, DeVone F, Oyebanji OA, et al. Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination. MedRxiv Prepr Serv Health Sci. 2023;4:e239.","journal-title":"MedRxiv Prepr Serv Health Sci"},{"key":"1346_CR13","doi-asserted-by":"publisher","unstructured":"Chalkias S, McGhee N, Whatley JL, et al. Safety and immunogenicity of XBB.1.5-containing mRNA vaccines infectious diseases (except HIV\/AIDS), 2023. Available at http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2023.08.22.23293434.","DOI":"10.1101\/2023.08.22.23293434"},{"key":"1346_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S1473-3099(23)00690-4","volume":"24","author":"MV Stankov","year":"2024","unstructured":"Stankov MV, Hoffmann M, Gutierrez Jauregui R, et al. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination. Lancet Infect Dis. 2024;24:e1\u20133.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1346_CR15","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S1473-3099(23)00779-X","volume":"24","author":"U Marking","year":"2024","unstructured":"Marking U, Bladh O, Aguilera K, et al. Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden. Lancet Infect Dis. 2024;24(2):e80\u20131.","journal-title":"Lancet Infect Dis"},{"key":"1346_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.15585\/mmwr.mm7204a4","volume":"72","author":"DH Canaday","year":"2023","unstructured":"Canaday DH, Oyebanji OA, White EM, et al. SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and Omicron BA.1 and BA.4\/BA.5 variants in nursing home residents after receipt of bivalent COVID-19 vaccine - Ohio and Rhode Island, September-November 2022. MMWR Morb Mortal Wkly Rep. 2023;72:100\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1346_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.15585\/mmwr.mm7304a2","volume":"73","author":"R Link-Gelles","year":"2024","unstructured":"Link-Gelles R, Ciesla AA, Mak J, et al. Early estimates of updated 2023-2024 (Monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to Co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024. MMWR Morb Mortal Wkly Rep. 2024;73:77\u201383.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1346_CR18","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1056\/NEJMc2302462","volume":"388","author":"D-Y Lin","year":"2023","unstructured":"Lin D-Y, Xu Y, Gu Y, et al. Durability of bivalent boosters against Omicron subvariants. N Engl J Med. 2023;388:1818\u201320.","journal-title":"N Engl J Med"},{"key":"1346_CR19","doi-asserted-by":"publisher","first-page":"eabn6150","DOI":"10.1126\/scitranslmed.abn6150","volume":"14","author":"A-RY Collier","year":"2022","unstructured":"Collier A-RY, Brown CM, McMahan KA, et al. Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant. Sci Transl Med. 2022;14:eabn6150.","journal-title":"Sci Transl Med"},{"key":"1346_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Bar-On YM, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386:2201\u201312.","journal-title":"N Engl J Med"},{"key":"1346_CR21","doi-asserted-by":"publisher","first-page":"104734","DOI":"10.1016\/j.ebiom.2023.104734","volume":"95","author":"HN Altarawneh","year":"2023","unstructured":"Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study. EBioMed. 2023;95:104734.","journal-title":"EBioMed"},{"key":"1346_CR22","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMc2209306","volume":"387","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Protective effect of previous SARS-CoV-2 infection against Omicron BA.4 and BA.5 subvariants. N Engl J Med. 2022;387:1620\u20132.","journal-title":"N Engl J Med"},{"key":"1346_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","volume":"228","author":"N Lasrado","year":"2023","unstructured":"Lasrado N, Barouch DH. SARS-CoV-2 hybrid immunity: the best of both worlds. J Infect Dis. 2023;228:1311\u20133.","journal-title":"J Infect Dis"},{"issue":"5","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"101048","DOI":"10.1016\/j.xcrm.2023.101048","volume":"4","author":"P Kaplonek","year":"2023","unstructured":"Kaplonek P, Deng Y, Shih-Lu Lee J, et al. Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines. Cell Rep Med. 2023;4(5):101048. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101048.","journal-title":"Cell Rep Med"},{"key":"1346_CR25","doi-asserted-by":"publisher","first-page":"100766","DOI":"10.1016\/j.bj.2024.100766","volume":"12","author":"JH Lee","year":"2024","unstructured":"Lee JH, Sergi C, Kast RE, et al. Basic implications on three pathways associated with SARS-CoV-2. Biomed J. 2024;12:100766. https:\/\/doi.org\/10.1016\/j.bj.2024.100766.","journal-title":"Biomed J"},{"key":"1346_CR26","doi-asserted-by":"publisher","unstructured":"Jong hoon Lee, Consolato Sergi, Richard E. Kast et al. The picture theory of seven pathways associated with COVID-19 in the real world. 2024; PREPRINT (Version 2) available at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-3849399\/v2","DOI":"10.21203\/rs.3.rs-3849399\/v2"},{"key":"1346_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert PB, Montefiori DC, McDermott AB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022;375:43\u201350.","journal-title":"Science"},{"key":"1346_CR28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, Phillips DJ, White T, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27:2032\u201340.","journal-title":"Nat Med"},{"key":"1346_CR29","doi-asserted-by":"publisher","first-page":"e28164","DOI":"10.1002\/jmv.28164","volume":"95","author":"J Favresse","year":"2023","unstructured":"Favresse J, Gillot C, Bayart J-L, et al. Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster. J Med Virol. 2023;95:e28164.","journal-title":"J Med Virol"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01346-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-024-01346-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01346-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:00:27Z","timestamp":1744477227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-024-01346-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s11357-024-01346-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.21.24303684","asserted-by":"object"}]},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.G. and D.H.C. are recipients of investigator-initiated grants to their Universities from Pfizer, to study pneumococcal vaccines (S.G. and D.H.C.), Sanofi Pasteur and Seqirus, to study influenza vaccines (S.G., D.H.C. and YA, Genentech, to study influenza antivirals (S.G. and YA), GSK to study shingles vaccine (S.G.), and a collaborative grant from Moderna on respiratory infection in long-term care (S.G., D.H.C., and YA). S. G. also consults for Janssen, Moderna, Novavax, Pfizer, Seqirus, and Sanofi and has received honoraria for speaking for GSK, Novavax, Pfizer, Sanofi, and Seqirus; YA is recipient of a grant from Centers for Disease Control and Prevention on The Kinetics of SARS-CoV-2 Shedding in Nursing Home Staff and Residents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The sponsor had no role in the design, methods, data analysis, or preparation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}